Pharma Deals Review, Vol 2004, No 45 (2004)

Font Size:  Small  Medium  Large

Wyeth Licenses Hedgehog Technology for Nervous Disorders

Business Review Editor

Abstract


Curis licensed its small molecule Hedgehog pathway agonists to Wyeth Pharmaceuticals for the treatment of neurological disorders, including Parkinson’s disease and stroke. The deal is valued at US$170 M.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.